ZAP-70 immunoreactivity is a prognostic marker of diseaseprogression in chronic lymphocytic leukemia
Claudia Vener(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Umberto Gianelli(University of Milan), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Silvano Bòsari(Ospedale Maggiore), Nicola Stefano Fracchiolla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), F. Somalvico(University of Milan), Maria Cristina Pasquini(Azienda Ospedaliera Ospedale Maggiore), Federica Savi(University of Milan)
Cited by 16
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553